Evidence map›Paper›PMID 26545606›Full record

ReviewLangenbeck's archives of surgery2015

Completion pancreatectomy for recurrent pancreatic cancer in the remnant pancreas: report of six cases and a review of the literature.

Yasuo Shima, Takehiro Okabayashi, Akihito Kozuki, Tatsuaki Sumiyoshi, Teppei Tokumaru, Yuichi Saisaka, Keiichi Date, Jun Iwata

Abstract readCase ReportsReview
PubMed Publisher
In one paragraph

Review in Langenbeck's archives of surgery, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.3field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 35 citations in OpenAlex.

  1. Remnant pancreatic carcinoma: The current status.World journal of clinical oncology · 2025
    Review
  2. How relevant is the mouse model for understanding human sex determination?International journal of biological sciences · 2025
    Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. [Surgery for isolated local recurrence and metachronous oligometastasis in pancreatic cancer].Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen · 2020
    Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Yasuo ShimaDepartment of Gastroenterological Surgery, Kochi Health Sciences Center, 2125-1 Ike, Kochi, 781-8555, Japan. yasuo_shima@khsc.or.jp.
Takehiro OkabayashiDepartment of Gastroenterological Surgery, Kochi Health Sciences Center, 2125-1 Ike, Kochi, 781-8555, Japan.
Akihito KozukiDepartment of Gastroenterological Surgery, Kochi Health Sciences Center, 2125-1 Ike, Kochi, 781-8555, Japan.
Tatsuaki SumiyoshiDepartment of Gastroenterological Surgery, Kochi Health Sciences Center, 2125-1 Ike, Kochi, 781-8555, Japan.
Teppei TokumaruDepartment of Gastroenterological Surgery, Kochi Health Sciences Center, 2125-1 Ike, Kochi, 781-8555, Japan.
Yuichi SaisakaDepartment of Gastroenterological Surgery, Kochi Health Sciences Center, 2125-1 Ike, Kochi, 781-8555, Japan.
Keiichi DateDepartment of Gastroenterological Surgery, Kochi Health Sciences Center, 2125-1 Ike, Kochi, 781-8555, Japan.
Jun IwataDepartment of Diagnostic Pathology, Kochi Health Sciences Center, Kochi, Japan.
CHI Health · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThere are no accepted surgical strategies for the treatment of pancreatic cancer recurrence in the remnant pancreas after initial resection. We retrospectively analyzed our experiences with patients undergoing completion pancreatectomy for recurrent pancreatic cancer in the remnant pancreas.

methodsSix patients with recurrent pancreatic cancer in the remnant pancreas underwent completion pancreatectomy between March 2005 and December 2012. Operative, postoperative, and pathological data and long-term outcomes for these six patients were analyzed retrospectively.

resultsThere was no operative morbidity or mortality associated with completion pancreatectomy. The median survival times were 49.0 and 27.5 months after initial resection and second pancreatectomy, respectively. However, all six patients died during follow-up. Five patients had recurrent pancreatic cancer at the time of death. One patient had no recurrence but had poor blood sugar control and eventually died after repeated bouts of cholangitis.

conclusionsCompletion pancreatectomy is a safe and effective option in select patients with local pancreatic cancer recurrence in the remnant pancreas after initial pancreatectomy. It is essential to select patients who have a good performance status and can tolerate major surgery and the resultant apancreatic state.

Indexed as

AgedAged, 80 and overFatal OutcomeFemaleHumansMaleMiddle AgedNeoplasm Recurrence, LocalPancreatectomyPancreatic NeoplasmsRetrospective StudiesLocal neoplasm recurrencePancreatectomyPancreatic cancerSurgery

Identifiers

PMID26545606
OpenAlexW2169830800

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.